A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
J Thorac Dis. 2019 Aug;11(8):3347-3359. doi: 10.21037/jtd.2019.08.22.
J Thorac Dis. 2019.
PMID: 31559038
Free PMC article.